Search results
Results from the WOW.Com Content Network
The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National Institute of Allergy and Infectious Diseases (NIAID), and the Biomedical Advanced Research and Development Authority (BARDA).
New Covid boosters approved as CDC set to decide who should receive them amid rising cases Monday 11 September 2023 19:38 , Graeme Massie Health officials say that the Pfizer and Moderna shots ...
Last year's fall booster was approved in mid-September 2023 and protected against XBB coronavirus strains, for example. But experts are predicting yet another wave to occur later in the year, as ...
Which companies have a new booster available? On Monday, the U.S. Food and Drug Administration approved new mRNA boosters from Moderna and Pfizer. Approval for another booster from Novavax is ...
An updated Coronavirus booster that targets a new variant is expected to be made available in September FDA approves updated Moderna and Pfizer Covid boosters set to arrive soon as cases rise ...
The FDA and CDC have approved new bivalent vaccines by Pfizer and Moderna that target both the original strain of COVID-19 and Omicron subvariants. New Omicron-targeting COVID-19 boosters are ...
On Friday, Moderna Inc. (NASDAQ:MRNA) announced that it has submitted an FDA application for review of its Spikevax 2024-2025 formula, which targets the SARS-CoV-2 variant JN.1. The submission is ...
U.S. regulators on Friday shortened the time that people who received Moderna's COVID-19 vaccine have to wait for a booster — to five months rather than six. The two-dose Moderna vaccine is open ...